Contrast

Contact

Share

Donate

MyChart

Help

Yale New Haven Hospital recognized one of the top three workplaces by Best Workplaces for Commuters

Monday, February 2, 2015

NEW HAVEN, CT (Feb. 2, 2015) – Yale New Haven Hospital (YNHH) , in addition to winning the Gold Medal by Best Workplaces for Commuters, also was recognized as the “Best of” , one of three organizations in the United States to be so designated. The Best Workplaces for Commuters is a program designed to encourage sustainable transportation nationwide. The announcement was made January 29 during the annual “Race to Excellence” Virtual Awards Ceremony. The awards recognize organizations who have taken exemplary steps to offer transportation options such as vanpool and transit benefits or telework and compressed workweek for their employees.

“We’re very pleased that Yale New Haven Hospital has been recognized and honored for the commitment we have shown to our employees to give them viable alternatives to their daily commute,” said Paul Patton, vice president, Employee Relations at YNHH. “Our employees are the life-blood of our organization and we recognize the importance of giving them alternatives that suit their individual lifestyles, enabling them to balance work/life challenges while treating our patients. “

 Best Workplaces for Commuters provides qualified employers with programs and services along with national recognition and an elite designation for offering outstanding commuter benefits, such as free or low cost bus passes. Employers that meet the National Standard of Excellence in commuter benefits, a standard established by the U.S. Environmental Protection Agency (EPA) and maintained by the National Center for Transit Research (NCTR), can become a member of Best Workplaces for Commuters.

“The annual Race to Excellence provides national recognition for employers who offer high level commuter benefits,” said Julie Bond, NCTR’s national program manager for Best Workplaces for Commuters. “Offering commuter benefits is a win-win situation for employees who change their commuting habits to save time, money, and stress and employers who gain a competitive edge in employee recruitment and retention. This year we recognized 25 Race to Excellence winners who have exceptional commute programs.” 

Bridgeport Hospital, part of Yale New Haven Health, is a non-profit 501-bed acute care hospital with two campuses (plus 42 beds licensed to Yale New Haven Children's Hospital). Its Bridgeport and Milford Campuses serve patients from across the region. The hospital admits more than 23,000 patients and provides nearly 350,000 outpatient treatments annually. The Connecticut Burn Center at Bridgeport Hospital is the only burn center in the state and one of only 64 verified burn centers in the United States. Bridgeport Hospital is committed to providing safe, compassionate and cost efficient care to its patients and the community. www.bridgeporthospital.org

Similar Articles

9/30/2021

Margaret Gilshannon named Deputy Director for Finance & Administration at Yale Cancer Center

New Haven, CT (September 30, 2021)— Margaret Gilshannon, MHA, has been appointed Deputy Director for Finance & Administration at Yale Cancer Center. Gilshannon joined Yale Cancer Center last year as Senior Director of Finance & Administration, while also leading the Integrated Business Operations for the Department of Pathology at Yale School of Medicine.

9/25/2021

Yale Cancer Center Study Demonstrates Efficacy of Risk Calculator in Treating Geriatric Patients with Cancer

New Haven, CT (Sept. 25, 2021) - Yale Cancer Center researchers show using a validated risk calculator helped drive informed treatment decisions in older patients with cancer.

9/17/2021

Yale Cancer Center Study Shows New Drug Combinations Improve Outcomes for Patients with Advanced Lung Cancer

New Haven, CT - New findings from a large study led by researchers at Yale Cancer Center shows the addition of the drugs oleclumab or monalizumab to durvalumab improved progression-free survival for patients with locally advanced non-small cell lung cancer (NSCLC).